<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value"/></p>
<p>纳斯达克 GM:ULBI 1 年股价与公允价值</p>
<p>探索 Ultralife 的社区公允价值并选择您的观点</p>
<p><strong>Ultralife Corporation</strong>（纳斯达克:ULBI）的股价在过去 30 天内大幅下跌了 25%，回吐了近期的许多涨幅。这 30 天的下跌为股东们带来了艰难的一年，股价在此期间下跌了 37%。</p>
<p>即使在如此大幅的价格下跌之后，Ultralife 目前可能仍在发出非常悲观的信号，市盈率（&#34;P/E&#34;）为 33.9 倍，因为美国几乎一半的公司市盈率低于 18 倍，甚至低于 11 倍的市盈率也并不罕见。然而，市盈率可能因某种原因而相对较高，需要进一步调查以确定其合理性。</p>
<p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
<p>尽管市场最近经历了盈利增长，但 Ultralife 的盈利却出现了逆转，这并不好。可能很多人预计悲观的盈利表现会大幅恢复，这使得市盈率没有崩溃。如果没有，那么现有股东可能会对股价的可行性感到极度紧张。</p>
<p>查看我们对 Ultralife 的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495"/></p>
<p>纳斯达克 GM:ULBI 市盈率与行业比较 2025 年 8 月 17 日</p>
<p>如果您想了解分析师对未来的预测，您应该查看我们关于 Ultralife 的 <strong>免费</strong> 报告。</p>
<h2>Ultralife 是否有足够的增长潜力？</h2>
<p>您唯一会真正感到舒适的情况是，当公司的增长有望明显超越市场时，才会看到像 Ultralife 这样陡峭的市盈率。</p>
<p>首先回顾一下，公司的每股收益增长去年并不令人兴奋，出现了令人失望的 69% 的下降。不幸的是，这使得它回到了三年前的起点，在此期间每股收益的增长几乎不存在。因此，股东们可能对不稳定的中期增长率并不太满意。</p>
<p>展望未来，唯一覆盖该公司的分析师的估计显示，预计明年的盈利将增长 306%。这显然高于更广泛市场的 15% 的增长预测。</p>
<p>考虑到这一点，Ultralife 的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
<h2>Ultralife 市盈率的底线</h2>
<p>Ultralife 的股价可能已经回落，但其市盈率仍然高企。通常情况下，我们会警告在做出投资决策时不要过于依赖市盈率，尽管它可以揭示其他市场参与者对公司的看法。</p>
<p>正如我们所怀疑的，我们对 Ultralife 分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。在这种情况下，投资者认为盈利恶化的潜力不足以证明较低的市盈率。在这种情况下，很难看到股价在不久的将来大幅下跌。</p>
<p>那么其他风险呢？每家公司都有风险，我们发现了 <strong>1 个 Ultralife 的警告信号</strong>，您应该了解。</p>
<p>如果您对 Ultralife 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的具有良好商业基础的其他公司呢？</p>

ULBI

<p>Ultralife Corporation（纳斯达克代码：ULBI）的股价在过去 30 天内下跌了 25%，导致年内累计下降了 37%。尽管出现这种下滑，该公司的高市盈率为 33.9 倍，表明投资者对未来盈利增长持乐观态度，预计明年的增长率将达到 306%，远高于市场平均水平的 15%。然而，该公司在过去一年中每股收益下降了 69%，引发了对其财务稳定性的担忧。投资者保持谨慎，但对复苏仍抱有希望</p>

<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value" alt="" original-src="https://images.simplywall.st/company/E0B545B3-693C-4CB6-A4B6-A1C7CA8CBEEB/chart/price-vs-fair-value"/></p>
<p>NasdaqGM:ULBI 1 Year Share Price vs Fair Value</p>
<div class="lb-trans"><p>纳斯达克 GM:ULBI 1 年股价与公允价值</p>
</div><p>Explore Ultralife's Fair Values from the Community and select yours</p>
<div class="lb-trans"><p>探索 Ultralife 的社区公允价值并选择您的观点</p>
</div><p>The <strong>Ultralife Corporation</strong> (NASDAQ:ULBI) share price has softened a substantial 25% over the previous 30 days, handing back much of the gains the stock has made lately. The drop over the last 30 days has capped off a tough year for shareholders, with the share price down 37% in that time.</p>
<div class="lb-trans"><p><strong>Ultralife Corporation</strong>（纳斯达克:ULBI）的股价在过去 30 天内大幅下跌了 25%，回吐了近期的许多涨幅。这 30 天的下跌为股东们带来了艰难的一年，股价在此期间下跌了 37%。</p>
</div><p>Even after such a large drop in price, Ultralife may still be sending very bearish signals at the moment with a price-to-earnings (or &#34;P/E&#34;) ratio of 33.9x, since almost half of all companies in the United States have P/E ratios under 18x and even P/E's lower than 11x are not unusual. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.</p>
<div class="lb-trans"><p>即使在如此大幅的价格下跌之后，Ultralife 目前可能仍在发出非常悲观的信号，市盈率（&#34;P/E&#34;）为 33.9 倍，因为美国几乎一半的公司市盈率低于 18 倍，甚至低于 11 倍的市盈率也并不罕见。然而，市盈率可能因某种原因而相对较高，需要进一步调查以确定其合理性。</p>
</div><p>Trump has pledged to &#34;unleash&#34; American oil and gas and these 15 US stocks have developments that are poised to benefit.</p>
<div class="lb-trans"><p>特朗普承诺要&#34;释放&#34;美国的石油和天然气，这 15 只美国股票的发展有望受益。</p>
</div><p>While the market has experienced earnings growth lately, Ultralife's earnings have gone into reverse gear, which is not great. It might be that many expect the dour earnings performance to recover substantially, which has kept the P/E from collapsing. If not, then existing shareholders may be extremely nervous about the viability of the share price.</p>
<div class="lb-trans"><p>尽管市场最近经历了盈利增长，但 Ultralife 的盈利却出现了逆转，这并不好。可能很多人预计悲观的盈利表现会大幅恢复，这使得市盈率没有崩溃。如果没有，那么现有股东可能会对股价的可行性感到极度紧张。</p>
</div><p>Check out our latest analysis for Ultralife</p>
<div class="lb-trans"><p>查看我们对 Ultralife 的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495" alt="" original-src="https://images.simplywall.st/asset/chart/322457-pe-multiple-vs-industry-1-dark-2/1755432806495"/></p>
<p>NasdaqGM:ULBI Price to Earnings Ratio vs Industry August 17th 2025</p>
<div class="lb-trans"><p>纳斯达克 GM:ULBI 市盈率与行业比较 2025 年 8 月 17 日</p>
</div><p>If you'd like to see what analysts are forecasting going forward, you should check out our <strong>free</strong> report on Ultralife.</p>
<div class="lb-trans"><p>如果您想了解分析师对未来的预测，您应该查看我们关于 Ultralife 的 <strong>免费</strong> 报告。</p>
</div><h2>Is There Enough Growth For Ultralife?</h2>
<div class="lb-trans"><h2>Ultralife 是否有足够的增长潜力？</h2>
</div><p>The only time you'd be truly comfortable seeing a P/E as steep as Ultralife's is when the company's growth is on track to outshine the market decidedly.</p>
<div class="lb-trans"><p>您唯一会真正感到舒适的情况是，当公司的增长有望明显超越市场时，才会看到像 Ultralife 这样陡峭的市盈率。</p>
</div><p>Taking a look back first, the company's earnings per share growth last year wasn't something to get excited about as it posted a disappointing decline of 69%. Unfortunately, that's brought it right back to where it started three years ago with EPS growth being virtually non-existent overall during that time. Accordingly, shareholders probably wouldn't have been overly satisfied with the unstable medium-term growth rates.</p>
<div class="lb-trans"><p>首先回顾一下，公司的每股收益增长去年并不令人兴奋，出现了令人失望的 69% 的下降。不幸的是，这使得它回到了三年前的起点，在此期间每股收益的增长几乎不存在。因此，股东们可能对不稳定的中期增长率并不太满意。</p>
</div><p>Shifting to the future, estimates from the sole analyst covering the company suggest earnings should grow by 306% over the next year. That's shaping up to be materially higher than the 15% growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未来，唯一覆盖该公司的分析师的估计显示，预计明年的盈利将增长 306%。这显然高于更广泛市场的 15% 的增长预测。</p>
</div><p>In light of this, it's understandable that Ultralife's P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>考虑到这一点，Ultralife 的市盈率高于大多数其他公司是可以理解的。似乎大多数投资者都在期待这种强劲的未来增长，并愿意为该股票支付更高的价格。</p>
</div><h2>The Bottom Line On Ultralife's P/E</h2>
<div class="lb-trans"><h2>Ultralife 市盈率的底线</h2>
</div><p>Ultralife's shares may have retreated, but its P/E is still flying high. Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.</p>
<div class="lb-trans"><p>Ultralife 的股价可能已经回落，但其市盈率仍然高企。通常情况下，我们会警告在做出投资决策时不要过于依赖市盈率，尽管它可以揭示其他市场参与者对公司的看法。</p>
</div><p>As we suspected, our examination of Ultralife's analyst forecasts revealed that its superior earnings outlook is contributing to its high P/E. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.</p>
<div class="lb-trans"><p>正如我们所怀疑的，我们对 Ultralife 分析师预测的审查显示，其优越的盈利前景正在推动其高市盈率。在这种情况下，投资者认为盈利恶化的潜力不足以证明较低的市盈率。在这种情况下，很难看到股价在不久的将来大幅下跌。</p>
</div><p>And what about other risks? Every company has them, and we've spotted <strong>1 warning sign for Ultralife</strong> you should know about.</p>
<div class="lb-trans"><p>那么其他风险呢？每家公司都有风险，我们发现了 <strong>1 个 Ultralife 的警告信号</strong>，您应该了解。</p>
</div><p>If you're <strong>unsure about the strength of Ultralife's business</strong>, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.</p>
<div class="lb-trans"><p>如果您对 Ultralife 的业务实力 <strong>不确定</strong>，为什么不探索我们互动式的股票列表，寻找一些您可能错过的具有良好商业基础的其他公司呢？</p>
</div>

尽管 Ultralife Corporation（NASDAQ:ULBI）的股价下跌了 25%，但仍然与投资者的看法一致